Narrow List by Age:
(Refer to Clinical Summary for age requirements)
Protocol | SWOG S2212 |
---|---|
Cancer Type: | Breast |
Fast Facts |
SHORTER ANTHRACYCLINE-FREE CHEMO IMMUNOTHERAPY ADAPTED TO PATHOLOGICAL RESPONSE IN EARLY TRIPLE NEGATIVE BREAST CANCER (SCARLET), A RANDOMIZED PHASE III STUDY |
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | Alliance A011801 |
---|---|
Cancer Type: | HER2 positive Breast Cancer |
Fast Facts |
The COMPASSHER2 Trials (COMprehensive Use of Pathologic Response ASSessment to Optimize Therapy in HER2-Positive Breast Cancer): COMPASSHER2 Residual Disease (RD), A Double-Blinded, Phase III Randomized Trial of T-DM1 and Placebo Compared with T-DM1 and Tucatinib
Protocol | Alliance A012103 |
---|---|
Cancer Type: | Breast- Post-Neoadjuvant |
Fast Facts |
OPTIMICE-PCR: DE-ESCALATION OF THERAPY IN EARLY-STAGE TNBC PATIENTS WHO ACHIEVE PCR AFTER NEOADJUVANT CHEMOTHERAPY WITH CHECKPOINT INHIBITOR THERAPY
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | CCTG MA.39 Adjuvant |
---|---|
Cancer Type: | LOW RISK NODE POSITIVE BREAST CANCER |
Fast Facts |
TAILOR RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low Risk Node Positive Breast Cancer
Protocol | NRG BR007 |
---|---|
Cancer Type: | Stage 1, Hormone Sensitive Her2 negative |
Fast Facts |
Phase III Clinical Trial Evaluating De-Escalation of Breast Radiation for Conservative Treatment of Stage 1, Hormone Sensitive HER2-Negative, Oncotype Recurrence Score < 18 Breast Cancer (DEBRA) De-Escalation of Breast Radiation
Protocol | NRG BR009 |
---|---|
Cancer Type: | Breast |
Fast Facts |
Protocol NRG-BR009, A Phase III Adjuvant Trial Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression plus Endocrine Therapy in Premenopausal Patients with pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score ≤ 25 (OFSET) (NCT05879926)
Protocol | NRG BR008 |
---|---|
Cancer Type: | Breast |
Fast Facts |
NRG-BR008, "A Phase III Randomized Trial of Radiotherapy Optimization for Low-Risk HER2-Positive Breast Cancer” (HERO)
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | SWOG S2007 |
---|---|
Cancer Type: | HER2-Negative Breast Cancer |
Fast Facts |
A Phase II Trial of Sacituzumab Govitecan for Patients with HER2-Negative Breast Cancer and Brain Metastases
Protocol | EAY191 - N2 |
---|---|
Cancer Type: | Rare Cancer |
Fast Facts |
PHASE 2 TRIAL OF FULVESTRANT AND BINIMETINIB IN PATIENTS WITH HORMONE RECEPTOR-POSITIVE METASTATIC BREAST CANCER WITH A FRAMESHIFT OR NONSENSE MUTATION OR GENOMIC DELETION IN NF1
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | SWOG S2010 |
---|---|
Cancer Type: | Breast |
Fast Facts |
A Randomized Phase III Trial Comparing Active Symptom Monitoring Plus Patient Education Versus Patient Education Alone To Improve Persistence With Endocrine Therapy In Young Women With Stage I-III Breast Cancer (Aspen)
Protocol | WF 2202 |
---|---|
Cancer Type: | Breast |
Fast Facts |
WF-2202, Optimizing Psychosocial Intervention for Breast Cancer-related Sexual Morbidity: The Sexual Health and Intimacy Education (SHINE) Trial
Protocol | EAQ221CD |
---|---|
Cancer Type: | Breast |
Fast Facts |
EAQ221CD: Improving Medication Adherence in Metastatic Breast Cancer using a CONnected CUstomized Treatment Platform (CONCURxP)
Protocol | SWOG S1703 |
---|---|
Cancer Type: | METASTATIC BREAST CANCER |
Fast Facts |
Randomized Non-Inferiority Trial Comparing Overall Survival of Patients Monitored With Serum Tumor Marker Directed Disease Monitoring (STMDDM) Versus Usual Care in Patients With Metastatic Hormone Receptor Positive HER-2 Negative Breast Cancer
Protocol | Alliance A191901 |
---|---|
Cancer Type: | Cancer Control |
Fast Facts |
Optimizing Endocrine Therapy Through Motivational Interviewing and Text Interventions
Protocol | PDM 9846 |
---|---|
Cancer Type: | Tissue Procurement |
Fast Facts |
Patient-Derived Models Tissue Procurement Protocol for the National Cancer Institute (NCI)
Protocol | NRG CC011 |
---|---|
Cancer Type: | Breast |
Fast Facts |
NRG CC011-Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors: A Multi-Center Randomized Double-Blinded Controlled Trial
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | EA1151 (TMIST) |
---|---|
Cancer Type: | Screening |
Fast Facts |
Tomosynthesis Mammographic Imaging Screening Trial (TMIST)
Please check out the rare protocol list to locate other studies within this disease site.
Cancer clinical trials are research studies for developing better ways of detecting,
treating, and eventually preventing cancer. By taking part in a clinical trial,
you are among the first to receive new research treatments before they are widely
available. Your participation in a clinical trial will influence the future direction
of cancer care.
If you are interested in participating in a clinical trial, consult with your physician.
Please note: clinical trials are not risk free. Patients must explore the options
that are best for their individuals needs with the help of their physician.